Table C.2.
Strain | Dose and animals per group | Duration/time of observation | Main effects observed | Effect level | Reference |
---|---|---|---|---|---|
Danish Landrace‐Duroc (♀) | Gelatin capsules containing OTA equivalent to 0, 0.2 and 1 mg/kg feed, n = 6 | 1–5 weeks |
|
0.2 mg/kg feed (based on kidney lesions) | Krogh et al. (1988), Meisner and Krogh (1986) |
Danish Landrace (♀) | 0, 0.2, 1, 4 mg/kg feed (corresponding to ~ 8, 40, and 160 μg/kg bw), n = 4–9 | 3–4 months (i.e. from 20 to 90 kg bw) |
|
0.2 mg/kg feed (corresponding to 8 μg/kg bw) (based on kidney lesions) | Krogh et al. (1974) |
Danish Landrace (♀) | 0, 30–50 μg/kg bw (gelatin capsule) (corresponding to 0 and 1 mg/kg feed), n = 3–6 | 3 months |
|
0, 30‐50 μg/kg bw (corresponding to 0 and 1 mg/kg feed) (based on kidney lesions) | Krogh et al. (1976, 1979), Elling (1979a, 1979b) |
2 years |
|
0, 30–50 μg/kg bw (corresponding to 0 and 1 mg/kg feed) (based on kidney lesions) | Krogh et al. (1979), Elling (1979b) |
ACP: acid phosphatase; ALP: alkaline phosphatase; GLDH: glutamate dehydrogenase; ɣ‐GT: ɣ‐glutamyl transpeptidase; LAP: leucine aminopeptidase; NADH‐TR: NADH‐tetrazolium reductase; OTA: ochratoxin A; PEPCK: cytosolic phosphoenolpyruvate carboxykinase; SDH: succinate dehydrogenase; TmPAH: average maximal tubular excretion of PAH; TmPAH/CInulin: ratio between TmPAH and average renal clearance of inulin.